Abstract CT133: A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer with PD-L1 expression

Mapping Intimacies ◽

10.1158/1538-7445.am2018-ct133 ◽

2018 ◽

Author(s):

You Lu ◽

Meijuan Huang ◽

Tao Deng ◽

Xiaojuan Zhou ◽

Kun Yu ◽

...

Keyword(s):

Lung Cancer ◽

T Cells ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell Lung ◽

Engineered T Cells

Download Full-text

A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.3050 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 3050-3050 ◽

Author(s):

You Lu ◽

Jianxin Xue ◽

Tao Deng ◽

Xiaojuan Zhou ◽

Kun Yu ◽

...

Keyword(s):

Lung Cancer ◽

T Cells ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell Lung ◽

Engineered T Cells

Download Full-text

Treatment of metastatic non‑small cell lung cancer with NY‑ESO‑1 specific TCR engineered‑T cells in a phase I clinical trial: A case report

Oncology Letters ◽

10.3892/ol.2018.9534 ◽

2018 ◽

Author(s):

Yan Xia ◽

Xiaopeng Tian ◽

Juntao Wang ◽

Dongjuan Qiao ◽

Xianhao Liu ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

T Cells ◽

Case Report ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Engineered T Cells

Download Full-text

Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy (CRT) for Patients with Locally Advanced Non–small-cell Lung Cancer (LANSCLC): A Phase I Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.266 ◽

2009 ◽

Vol 75 (3) ◽

pp. S110 ◽

Author(s):

J.H. Heinzerling ◽

R.S. Hughes ◽

R. Govindan ◽

J.D. Bradley ◽

J.D. Schiller ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Locally Advanced ◽

Small Cell Lung

Download Full-text

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1772-z ◽

2011 ◽

Vol 69 (2) ◽

pp. 563-571 ◽

Author(s):

Heather A. Wakelee ◽

Chris H. Takimoto ◽

Arturo Lopez-Anaya ◽

Quincy Chu ◽

Gary Middleton ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell Lung

Download Full-text

p53 gene therapy for non-small cell lung cancer: a preliminary report of phase I trial

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)47621-x ◽

2000 ◽

Vol 82 ◽

pp. 36

Author(s):

Toshivoshi Fujiwara ◽

Masafumi Kataoka ◽

Atsushi Nakamura ◽

Noriaki Tanaka

Keyword(s):

Lung Cancer ◽

Gene Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Preliminary Report ◽

Phase I Trial ◽

P53 Gene ◽

Small Cell Lung

Download Full-text

P-575 Preclinical and preliminary phase I trial results of motexafin gadolinium (MGd) with docetaxel & cisplatin in non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)81068-2 ◽

2005 ◽

Vol 49 ◽

pp. S269-S270

Author(s):

D. Stewart ◽

Y. Oh ◽

R. Schaerer ◽

L. Naumobski ◽

S. Phan

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell Lung ◽

Motexafin Gadolinium ◽

Preliminary Phase

Download Full-text

High-dose tamoxifen in combination with cisplatin in non-small cell lung cancer (NSCLC): Phase I trial and pharmacokinetic analysis

Lung Cancer ◽

10.1016/0169-5002(94)94216-1 ◽

1994 ◽

Vol 11 ◽

pp. 116

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Pharmacokinetic Analysis ◽

High Dose ◽

Small Cell Lung

Download Full-text

P-578 A phase I trial of gemcitabine, carboplatin or gemcitabine paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study

Lung Cancer ◽

10.1016/s0169-5002(05)81071-2 ◽

2005 ◽

Vol 49 ◽

pp. S270

Author(s):

S. Swann ◽

H. Choy ◽

C. Walter ◽

G. Whipple ◽

W. Demas ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/j.lungcan.2012.11.017 ◽

2013 ◽

Vol 79 (3) ◽

pp. 270-275 ◽

Author(s):

Se Hyun Kim ◽

Hyo Sup Shim ◽

Jaeho Cho ◽

Jae Heon Jeong ◽

Sun Mi Kim ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell Lung

Download Full-text

Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial

European Journal of Cancer ◽

10.1016/s0959-8049(97)86049-2 ◽

1997 ◽

Vol 33 ◽

pp. S252

Author(s):

R. Pirker ◽

G. Krajnik ◽

A. Mohn-Staudner ◽

F. Marhold ◽

R. Malayeri ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell Lung

Download Full-text